EN
FR
Exporter
exporter
Exporter
PDF
Excel (XLSX)
Word (DOCX)
You can select particular sections to be included in the output file.
Select all
Select classic EML layout
Indication
ICD-11
Codes ATC
Type de liste
Formulations
Équivalence thérapeutique
Footnote
INN
Type de médicament
Groupes d'antibiotiques
Sexe
Âge
Limite d'âge
Restriction de poids
Renseignements sur le brevet
Expert Committee decision justification
Cancel
Download
EN
FR
Liste modèle des médicaments essentiels
effacer
Trouvé 11 recommandations pour 4 médicaments et 0 équivalent thérapeutique
Les recommandations supprimées et les demandes rejetées sont affichées.
Les cacher
.
8.2.5. Supportive medicines
Allopurinol
Informations générales
Section
Supportive medicines
Oral > Solid: 100 mg; 300 mg
Indications
Tumour lysis syndrome
Mesna
Informations générales
Section
Supportive medicines
Parenteral > General injections > IV: 100 mg per mL in 4 mL ampoule; 100 mg per mL in 10 mL ampoule
Oral > Solid: 400 mg; 600 mg
Indications
Osteosarcoma of bone and articular cartilage of other specified sites
Other specified malignant neoplasms of the ovary
Germ cell tumour of testis
Ewing sarcoma of bone and articular cartilage of unspecified sites
Rhabdomyosarcoma primary site
Unspecified malignant neoplasms of ill-defined or unspecified sites
Burkitt lymphoma including Burkitt leukaemia
Malignant neoplasms of kidney, except renal pelvis
Rasburicase
Informations générales
Section
Supportive medicines
Parenteral > General injections > IV: 1.5 mg in vial powder and solvent for solution; 7.5 mg in vial powder and solvent for solution
Indications
Tumour lysis syndrome
Zoledronic acid
Informations générales
Section
Supportive medicines
Parenteral > General injections > IV: 4 mg per 5 mL in 5 mL vial; 4 mg per 100 mL in 100 mL bottle
Indications
Malignant neoplasm metastasis in bone or bone marrow